ENZYCHEM LIFESCIENCES CORPORATION
Develops small molecule therapeutics for cancer, inflammation, and respiratory diseases.
183490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7183490002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 제천시 바이오밸리로 59, 제천시
- Website:
- https://www.enzychem.com/
- Sector:
- Manufacturing
Description
Enzychem Lifesciences Corporation is a biopharmaceutical company that develops novel small molecule therapeutics. The company's research targets fundamental pathways in inflammation to address significant unmet medical needs for patients with cancer, inflammatory diseases, and severe respiratory conditions. Its leading drug candidate, EC-18 (Mosedipimod), is a first-in-class oral small molecule derived from Sika deer antler. The clinical pipeline for EC-18 includes indications such as chemoradiation-induced oral mucositis (CRIOM), chemotherapy-induced neutropenia (CIN), acute radiation syndrome (ARS), and non-alcoholic steatohepatitis (NASH). The company also develops and manufactures Active Pharmaceutical Ingredients (APIs).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-05 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.3 KB | ||
| 2025-02-04 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 85.1 KB | ||
| 2024-12-27 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 85.1 KB | ||
| 2024-12-10 00:00 |
주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 27.4 KB | ||
| 2024-12-10 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2024-11-19 00:00 |
[기재정정]투자판단관련주요경영사항 (COVID-19 pDNA백신(ZyCoV-D) 제조라이선스기술이전 계약 종료)
|
Korean | 17.9 KB | ||
| 2024-11-19 00:00 |
소송등의판결ㆍ결정(일정금액이상의청구)
|
Korean | 8.7 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.6 MB | ||
| 2024-11-08 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 84.6 KB | ||
| 2024-10-31 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (아토피 피부염 환자 대상 EC-18 제 2상 임상시험)
|
Korean | 10.6 KB | ||
| 2024-10-10 00:00 |
신탁계약해지결과보고서
|
Korean | 16.7 KB | ||
| 2024-09-26 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 85.3 KB | ||
| 2024-08-30 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.7 MB | ||
| 2024-08-12 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 86.3 KB |
Automate Your Workflow. Get a real-time feed of all ENZYCHEM LIFESCIENCES CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ENZYCHEM LIFESCIENCES CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ENZYCHEM LIFESCIENCES CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
